EV/EBITDA
14.07
-0.22-1.54%
Thu, 06 Feb 2025 23:17:08 GMT
Summary
- As of February 7, 2025, SUPN EV/EBITDA is 14.07, with a fall of -0.22 (-1.54%) during the most recent trading day.
- Over the past year, SUPN EV/EBITDA has dropped by -2.76 (-16.40%).
- SUPN EV/EBITDA is now -83.47% below its all-time high of 85.14.
Performance
SUPN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SUPN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -1.5% | -1.5% | -1.5% |
| 1 m1 month | +11.2% | +11.2% | +11.3% |
| 3 m3 months | +4.8% | +4.8% | +4.8% |
| 6 m6 months | +13.0% | +43.8% | +41.9% |
| ytdytd | +9.4% | +9.4% | +9.4% |
| 1 y1 year | -16.4% | +44.6% | +39.8% |
| 5 y5 years | +71.0% | +50.5% | +65.1% |
SUPN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.5% | 12.42 | +13.3% | |
| 3 m | 3-month | 14.29 | -1.5% | 12.42 | +13.3% |
| 6 m | 6-month | 15.73 | -10.6% | 10.95 | +28.5% |
| 1 y | 1-year | 23.48 | -40.1% | 10.95 | +28.5% |
| 3 y | 3-year | 23.48 | -40.1% | 9.53 | +47.6% |
| 5 y | 5-year | 23.48 | -40.1% | 5.41 | +160.1% |
| alltime | all time | 85.14 | -83.5% | -144.43 | +109.7% |
Supernus Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 14.07(+9.4%) |
| 2024 | 12.86(-25.3%) |
| 2023 | 17.21(+15.4%) |
| 2022 | 14.91(+8.4%) |
| 2021 | 13.75(+99.3%) |
| 2020 | 6.90(-15.4%) |
| 2019 | 8.16(-28.0%) |
| Date | Value |
|---|---|
| 2018 | 11.34(-35.7%) |
| 2017 | 17.63(-15.0%) |
| 2016 | 20.73(-33.4%) |
| 2015 | 31.14(-133.7%) |
| 2014 | -92.53(+2456.1%) |
| 2013 | -3.62(-25.1%) |
| 2012 | -4.83 |
FAQ
- What is Supernus Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Supernus Pharmaceuticals?
- What is SUPN EV/EBITDA year-to-date change?
- What is Supernus Pharmaceuticals EV/EBITDA year-on-year change?
What is Supernus Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of SUPN is 14.07
What is the all time high EV/EBITDA for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high EV/EBITDA is 85.14
What is SUPN EV/EBITDA year-to-date change?
Supernus Pharmaceuticals EV/EBITDA has changed by +1.21 (+9.41%) since the beginning of the year
What is Supernus Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, SUPN EV/EBITDA has changed by -2.76 (-16.40%)